MMP9 and neoplasm: MMP-9 may antagonize T cell–mediated anti-tumor responses in tumors by shaping a local inflammatory cytokine/chemokine milieu hostile to effector T-cell infiltration, and by increasing the recruitment and/or activation of MDSCs and other suppressive myeloid infiltrates to the tumor.